ZYBT logo

Zhengye Biotechnology Holding Limited Stock Price

NasdaqCM:ZYBT Community·US$98.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ZYBT Share Price Performance

US$2.12
-2.74 (-56.38%)
US$2.12
-2.74 (-56.38%)
Price US$2.12

ZYBT Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
0 Rewards

Zhengye Biotechnology Holding Limited Key Details

CN¥186.4m

Revenue

CN¥95.1m

Cost of Revenue

CN¥91.3m

Gross Profit

CN¥80.0m

Other Expenses

CN¥11.3m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
0.24
48.99%
6.07%
24.6%
View Full Analysis

About ZYBT

Founded
2004
Employees
277
CEO
Songlin Song
WebsiteView website
www.jlzybio.com

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Recent ZYBT News & Updates

Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) 26% Share Price Surge Not Quite Adding Up

Oct 28
Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) 26% Share Price Surge Not Quite Adding Up

Recent updates

No updates